We are live on !
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $7.45M invested in Tonix Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
5.64% more ownership
Funds ownership: 17.56% → 23.2% (+5.6%)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $750K
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$225K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$119K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$93K |
| 4 |
DAFNA Capital Management
Los Angeles,
California
|
-$93K |
| 5 |
FNY Managed Accounts
New York
|
-$88K |